(Q42167008)

17 October 2017

title

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade (English)

1 reference

17 October 2017

0 references

Jean-Charles Schwartz

series ordinal

2

object named as

Jean-Charles Schwartz

0 references

Pierre Sokoloff

series ordinal

3

object named as

Pierre Sokoloff

1 reference

17 October 2017

Ludovic Leriche

1

1 reference

17 October 2017

publication date

1 August 2003

1 reference

17 October 2017

1 reference

17 October 2017

volume

45

1 reference

17 October 2017

issue

2

1 reference

17 October 2017

page(s)

174-181

1 reference

A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

The current status of the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Recovery of neuropsychological functions during reduction in use of phencyclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Effect of Phencyclidine in Chronic Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

In vivo occupancy of D2 dopamine receptors by nafadotride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Role of dopamine D3 receptors in thermoregulation: a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Drug interactions on spontaneous locomotor activity in rats. Neuroleptics and amphetamine-induced hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Psychotogenic drugs as models for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900145-X

10.1016/S0028-3908(03)00145-X

7 January 2021

Identifiers

DOI

1 reference

17 October 2017

1 reference